4
Changes in Ownership
GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-002995
President sold 4,000 shares at an average $11.49 ($45,960)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ma Songjiang President | 2025-01-31 | Sale 10b5-1 | −2,000 | $11.51 | $23,020 | 2,889,138 | I |
| Ma Songjiang President | 2025-02-03 | Sale 10b5-1 | −2,000 | $11.47 | $22,940 | 2,887,138 | I |
| Open-market sales · 4,000 sh · avg $11.49 · $45,960 | |||||||
Loading xslF345X05/form4.xml…